Orchid in licensing & distribution alliance with Actavis

RELATED NEWS Orchid’s Betalactam API facility approved by UK MHRA Orchid Chemicals Q3 net profit at Rs 28.3cr Orchid Chem plans new launches every qtr ALSO READ See latest News about Orchid Chemical See previous management interviews See what other Experts & Brokerages are saying about Orchid Chemical Orchid Chemical BSE | NSE 25/05/12 Are Mutual Funds betting on Orchid Chemical?

 The Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals Ltd., (Orchid), today announced that it has entered into a licensing and distribution agreement with the international generic pharmaceuticals company Actavis for marketing 9 of Orchid's cephalosporin generic formulations in Europe, comprising all the EU (European Union) and CEE (Central & Eastern Europe) countries, numbering 37 in total.

 

Under this agreement, Orchid will develop and manufacture 9 cephalosporin formulations in specific dosage forms and strengths for licensing to and marketing by Actavis in Europe. Actavis would obtain its marketing authorizations based on Orchid's dossiers which will be provided on a non-exclusive basis to Actavis. Actavis will source all of these product requirements from Orchid exclusively. The products will be manufactured at Orchid's state-of-the-art sterile and oral API and dosage form facilities, which are approved by the US FDA and UK MHRA. Actavis would pay certain dossier license fees to Orchid based on milestones and share revenues arising from marketing of the products in the territory with Orchid. 

 

These 9 cephalosporin formulations licensed to Actavis under the agreement comprise both sterile and oral products. Orchid has already filed 10 dossiers with EU regulatory authorities which include some of the products under the agreement. Orchid will complete the balance filings required under this agreement over the next few months. With the facility approvals by the EU regulatory agencies on hand, Orchid would supply the products upon receipt of marketing authorisations by Actavis for marketing in the vast European geography.

 

contd on page 2...